IUPAC name
1-{bicyclo[2.2.1]hept-5-en-2-yl}-1-phenyl-3-(piperidin-1-yl)propan-1-ol
SMILES
OC(CCN1CCCCC1)(C1CC2CC1C=C2)C1=CC=CC=C1
Compound class
Antiparkinson Agents; Muscarinic Antagonists; Parasympatholytics; Antidyskinetics; Nervous System; Anti-Parkinson Drugs; Anticholinergics; Tertiary Amines; CYP2D6 Inducers; CYP2D6 Inducers (strong);
Therapeutic area
For use as an adjunct in the therapy of all forms of parkinsonism and control of extrapyramidal disorders secondary to neuroleptic drug therapy.
Common name
Biperiden
IUPAC name
1-{bicyclo[2.2.1]hept-5-en-2-yl}-1-phenyl-3-(piperidin-1-yl)propan-1-ol
SMILES
OC(CCN1CCCCC1)(C1CC2CC1C=C2)C1=CC=CC=C1
INCHI
InChI=1S/C21H29NO/c23-21(19-7-3-1-4-8-19,11-14-22-12-5-2-6-13-22)20-16-17-9-10-18(20)15-17/h1,3-4,7-10,17-18,20,23H,2,5-6,11-16H2
FORMULA
C21H29NO
Common name
Biperiden
IUPAC name
1-{bicyclo[2.2.1]hept-5-en-2-yl}-1-phenyl-3-(piperidin-1-yl)propan-1-ol
Molecular weight
311.461
clogP
3.660
clogS
-3.411
HBond Acceptor
2
HBond Donor
1
Total Polar Surface Area
23.47
Number of Rings
4
Rotatable Bond
5
| Drug ID | Common name | Structure CAS | SMILE | Frequency |
|---|---|---|---|---|
| FDBF00005 | benzene |
|
c1ccccc1 | 0.2824 |
| FDBF00018 | propan-1-ol |
|
C(O)CC | 0.0330 |
| FDBF00041 | ethanol |
|
CCO | 0.1474 |
| FDBF00670 | piperidine |
|
N1CCCCC1 | 0.0199 |
| FDBF00671 | 1-ethylpiperidine |
|
N1(CCCCC1)CC | 0.0106 |
| FDBF01063 | (1S)-1-phenylethanol |
|
c1(ccccc1)C(C)O | 0.0031 |
| FDBF01373 | 3-(1-piperidyl)propan-1-ol |
|
OCCCN1CCCCC1 | 0.0010 |
| FDBF01378 | norbornane |
|
C1C2CC(C1)CC2 | 0.0010 |
| FDBF01851 | [(1R,2S,4S)-norbornan-2-yl]methanol |
|
C1(C2CC(C1)CC2)CO | 0.0003 |
| FDBF01853 | (1R)-1-[(1R,2S,4S)-norbornan-2-yl]propan-1-ol |
|
CCC(C1C2CC(C1)CC2)O | 0.0003 |
